AbbVie Inc

AbbVie Inc (ABBV) SEC filings

AbbVie Inc (ABBV) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported ABBV revenue for 2026-03-31 was $15.00B. Net income was $695.0M. Revenue was down 75.5% from 2025-12-31 to 2026-03-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5. The ABBV filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what AbbVie Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

5

8-K

0

Form 4

Recent filings

8-K

8-K exhibit

EDGAR
8-K8.019.01

8-K exhibit

EDGAR
8-K2.029.01

8-K exhibit

EDGAR
8-K2.029.01

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all ABBV filings.

Frequently asked questions

What did ABBV just say?

ABBV cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are ABBV SEC filings?

5 cached filings are on this page. EDGAR remains the official archive (CIK 0001551152).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.

Explore Categories